Clinical Trials Logo

Human Papillomavirus Vaccine clinical trials

View clinical trials related to Human Papillomavirus Vaccine.

Filter by:
  • None
  • Page 1

NCT ID: NCT06158802 Recruiting - Chronic Condition Clinical Trials

Evaluation of Human Papillomavirus Vaccine Coverage in Girls and Young Women With Chronic Disease

MC-HPV
Start date: January 23, 2024
Phase:
Study type: Observational

The main objective of the study is to determine the vaccination coverage rate for human papillomavirus in adolescents aged 11 to 20 with chronic disease and treated at the Necker-Enfants Malades Hospital, compared to a population witnessed adolescent girls aged 11 to 20 years without chronic disease.

NCT ID: NCT03832049 Active, not recruiting - Clinical trials for Human Papillomavirus Vaccine

HPV Vaccination in Africa- New Delivery Schedules Alias The HANDS HPV Vaccine Trial

HPV
Start date: September 14, 2019
Phase: Phase 3
Study type: Interventional

A randomized, observer-blind non-inferiority trial to evaluate alternative human papillomavirus (HPV) vaccination schedules in young females in West Africa.

NCT ID: NCT01184079 Completed - Clinical trials for Human Papillomavirus Vaccine

Randomized Trial of Alternative HPV Vaccination Schedules in Males in a University Setting

Start date: October 2010
Phase: N/A
Study type: Interventional

The investigators propose a randomized, open label trial of the immunogenicity of HPV vaccine among males 18-24 years old, comparing an on-time administration of the third dose with delayed administration of the third dose. All participants would receive the first and second doses according to schedule. They would be randomized to either Dose 3 at 6 months or Dose 3 at 12 months. Hypothesis: The Geometric mean titers in the 12 month test group (T) are non-inferior to the usual timing control group (C): H0: δ ≤ −δ0 versus H1: δ > −δ0 where δ = log (GMTT )− log (GMTC) and δ0 is the pre-specified non-inferiority margin